News

Terbinafine HCl Tablets are the generic version of Novartis’ Lamisil tablets, which are used for fungal infections. Terbinafine HCl tablets had US sales of approximately $685 million for

The company claims that the drug, MAXY-G34, is a novel pegylated granulocyte colony stimulating factor (PEG-GCSF) shown in preclinical and phase I studies to have novel and potentially

The new formulation utilizes SkyePharma’s patented Geomatrix technology, which has been developed to provide a lower dose of Sular for each of its current doses. Sular is designed

According to the company, these results are the first that describe the protective immunity elicited by a multivalent vaccine that is active by the mucosal route. The vaccine

The companies say lixivaptan is a selective V2 vasopressin receptor antagonist that, in clinical trials, has demonstrated promising activity in treating hyponatremia, an imbalance of sodium and water

Researchers at the University of Pennsylvania tested CSA-13 in treating multidrug resistant pseudomonas aeuroginosa infections, which are a leading cause of morbidity and mortality in patients with cystic

The drug, ALX-0081, uses the company’s Nanobody technology to target to reduce the risk of thrombosis in patients with acute coronary syndrome. The phase I study in healthy

Vyvanse is a prodrug stimulant that is therapeutically inactive until metabolized in the body and active d-amphetamine is released. Shire says the drug is different from other oral

Within this additional program, Galapagos will progress a disease-modifying drug towards completion of clinical phase IIa, at which point GSK’s R&D organization will be responsible for the late-stage